China Resources Medical Holdings Company Limited

SEHK:1515 Lagerbericht

Marktkapitalisierung: HK$5.2b

China Resources Medical Holdings Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

China Resources Medical HoldingsDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -6% zurückgegangen, während in der Branche Healthcare die Gewinne wachsen. Die Umsatzerlöse sind gewachsen mit einer durchschnittlichen Rate von 35.9% pro Jahr. China Resources Medical Holdings Die Eigenkapitalrendite des Unternehmens beträgt 4.7%, und die Nettomargen liegen bei 2.5%.

Wichtige Informationen

-3.9%

Wachstumsrate der Gewinne

-4.1%

EPS-Wachstumsrate

Healthcare Wachstum der Industrie11.3%
Wachstumsrate der Einnahmen36.4%
Eigenkapitalrendite4.7%
Netto-Marge2.9%
Letzte Ertragsaktualisierung30 Jun 2024

Jüngste Aktualisierungen vergangener Leistungen

We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings

May 06
We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings

Recent updates

We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings

May 06
We Think You Can Look Beyond China Resources Medical Holdings' (HKG:1515) Lackluster Earnings

China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Apr 26
China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price

Mar 09
Shareholders Should Be Pleased With China Resources Medical Holdings Company Limited's (HKG:1515) Price

Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?

Nov 29
Is China Resources Medical Holdings (HKG:1515) Using Too Much Debt?

China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall

Oct 19
China Resources Medical Holdings' (HKG:1515) Returns Have Hit A Wall

Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Aug 30
Analyst Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?

Aug 26
Should You Think About Buying China Resources Medical Holdings Company Limited (HKG:1515) Now?

China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

Jun 30
China Resources Medical Holdings (HKG:1515) Has A Pretty Healthy Balance Sheet

China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

May 12
China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)

Apr 03
Analysts Just Published A Bright New Outlook For China Resources Medical Holdings Company Limited's (HKG:1515)

Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Feb 21
Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital

Jan 10
China Resources Medical Holdings (HKG:1515) May Have Issues Allocating Its Capital

We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Nov 30
We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?

Oct 18
Is China Resources Medical Holdings Company Limited (HKG:1515) Trading At A 23% Discount?

China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends

Sep 21
China Resources Medical Holdings (HKG:1515) Will Want To Turn Around Its Return Trends

Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?

Jul 13
Are Investors Undervaluing China Resources Medical Holdings Company Limited (HKG:1515) By 47%?

Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Jun 24
Is It Time To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12

Jun 03
China Resources Medical Holdings (HKG:1515) Is Increasing Its Dividend To HK$0.12

China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12

Apr 27
China Resources Medical Holdings (HKG:1515) Will Pay A Larger Dividend Than Last Year At HK$0.12

We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Apr 22
We Think China Resources Medical Holdings (HKG:1515) Can Manage Its Debt With Ease

Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%

Mar 30
Growth Investors: Industry Analysts Just Upgraded Their China Resources Medical Holdings Company Limited (HKG:1515) Revenue Forecasts By 45%

Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?

Jan 27
Is Now An Opportune Moment To Examine China Resources Medical Holdings Company Limited (HKG:1515)?

China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jan 03
China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 37% Below Their Intrinsic Value Estimate

China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Nov 19
China Resources Medical Holdings (HKG:1515) Will Be Hoping To Turn Its Returns On Capital Around

Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

Oct 26
Is It Too Late To Consider Buying China Resources Medical Holdings Company Limited (HKG:1515)?

An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued

Sep 20
An Intrinsic Calculation For China Resources Medical Holdings Company Limited (HKG:1515) Suggests It's 44% Undervalued

Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly

Sep 06
Here's Why China Resources Medical Holdings (HKG:1515) Can Manage Its Debt Responsibly

China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively

Aug 17
China Resources Medical Holdings (HKG:1515) Might Be Having Difficulty Using Its Capital Effectively

Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

Jun 21
Broker Revenue Forecasts For China Resources Medical Holdings Company Limited (HKG:1515) Are Surging Higher

China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate

Jun 09
China Resources Medical Holdings Company Limited (HKG:1515) Shares Could Be 34% Below Their Intrinsic Value Estimate

Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality

May 03
Investors Can Find Comfort In China Resources Medical Holdings' (HKG:1515) Earnings Quality

China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?

Apr 22
China Resources Medical Holdings Company Limited (HKG:1515) Is Yielding 1.4% - But Is It A Buy?

We Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt

Mar 27
We Think China Resources Medical Holdings (HKG:1515) Can Stay On Top Of Its Debt

Should You Be Impressed By China Resources Medical Holdings' (HKG:1515) Returns on Capital?

Mar 12
Should You Be Impressed By China Resources Medical Holdings' (HKG:1515) Returns on Capital?

Should You Investigate China Resources Medical Holdings Company Limited (HKG:1515) At HK$6.66?

Feb 27
Should You Investigate China Resources Medical Holdings Company Limited (HKG:1515) At HK$6.66?

Aufschlüsselung der Einnahmen und Ausgaben

Wie China Resources Medical Holdings Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

SEHK:1515 Einnahmen, Ausgaben und Erträge (CNY Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Jun 249,9702941,0690
31 Mar 2410,0392761,0610
31 Dec 2310,1082581,0530
30 Sep 239,9583381,0250
30 Jun 239,8094199970
31 Mar 238,8553429310
31 Dec 227,9012668640
30 Sep 226,8913657790
30 Jun 225,8814636950
31 Mar 225,1644416300
31 Dec 214,4474185660
30 Sep 214,0314105040
30 Jun 213,6154024410
31 Mar 213,1833564000
31 Dec 202,7513103580
30 Sep 202,4043133060
30 Jun 202,0583152530
31 Mar 202,0873532530
31 Dec 192,1153912540
30 Sep 192,1124012440
30 Jun 192,1084122350
31 Mar 192,0844212290
31 Dec 182,0594312230
30 Sep 181,9963642250
30 Jun 181,9322982270
31 Mar 181,9053602190
31 Dec 171,8784212120
30 Sep 171,784-4462040
30 Jun 171,690-1,3121960
31 Mar 171,611-1,4101840
31 Dec 161,533-1,5071720
30 Sep 161,504-6561670
30 Jun 161,4751961630
31 Mar 161,4241811560
31 Dec 151,3721671500
30 Sep 151,3372081240
30 Jun 151,302249970
31 Mar 151,254240910
31 Dec 141,206230860
30 Sep 141,090176850
30 Jun 14975122840
31 Mar 14931106790
31 Dec 1388790740
30 Sep 13872101670

Qualität der Erträge: 1515 hat einen großen einmalig Verlust von CN¥370.7M, der sich auf die Finanzergebnisse der letzten 12 Monate auswirkt, an 31st December, 2023.

Wachsende Gewinnspanne: 1515Die aktuellen Gewinnspannen (2.5%) sind niedriger als im letzten Jahr (3.4%).


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 1515Die Erträge des Unternehmens sind in den letzten 5 Jahren um 6% pro Jahr zurückgegangen.

Beschleunigtes Wachstum: 1515Das Unternehmen hat im vergangenen Jahr ein negatives Gewinnwachstum verzeichnet, so dass es nicht mit seinem 5-Jahres-Durchschnitt verglichen werden kann.

Erträge im Vergleich zur Industrie: 1515 hatte im vergangenen Jahr ein negatives Gewinnwachstum (-29.8%), was einen Vergleich mit dem Branchendurchschnitt Healthcare (-11.6%) erschwert.


Eigenkapitalrendite

Hohe Eigenkapitalrendite: 1515Die Eigenkapitalrendite des Unternehmens (4.7%) wird als niedrig angesehen.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren